Organogenesis

ORGONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$239.335 M

$1.86 -22.82%

Close of 7 Aug 2026

Revenue

$564.2M

#1855 by revenue

Earnings

$37.0M

#1686 by earnings

Shares outstanding

128,674,548

Latest filing cover page

P/E ratio

6.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#255Sol-Gel TechnologiesSLGL$247.3M
#256AC ImmuneACIU$240.2M
#257OrganogenesisORGO$239.3M
#258Capricor TherapeuticsCAPR$236.9M
#259Pyxis OncologyPYXS$236.3M

Where these numbers come from

Share counts and financials for Organogenesis are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.